OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The mechanisms of immune response and evasion by the main SARS-CoV-2 variants
Qiuli Chen, Jiawei Zhang, Peter Wang, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105044-105044
Open Access | Times Cited: 21

Showing 21 citing articles:

Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants
Luyi Chen, Ying He, Hongye Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8

SARS-CoV-2 infection and immune responses
Rakhi Harne, Brittany Williams, Hazem F. M. Abdelaal, et al.
AIMS Microbiology (2023) Vol. 9, Iss. 2, pp. 245-276
Open Access | Times Cited: 11

A SARS-CoV-2: Companion Animal Transmission and Variants Classification
Rachana Pandit, Qiana L. Matthews
Pathogens (2023) Vol. 12, Iss. 6, pp. 775-775
Open Access | Times Cited: 7

Humoral immune responses associated with control of SARS-CoV-2 breakthrough infections in a vaccinated US military population
Gregory D. Gromowski, Camila Macedo Cincotta, Sandra V. Mayer, et al.
EBioMedicine (2023) Vol. 94, pp. 104683-104683
Open Access | Times Cited: 6

Ligand-based discovery of coronavirus main protease inhibitors using MACAW molecular embeddings
Jie Dong, Mihayl Varbanov, Stéphanie Philippot, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 24-35
Open Access | Times Cited: 10

Mechanistic Insights into the Mutational Landscape of the Main Protease/3CLPro and Its Impact on Long-Term COVID-19/SARS-CoV-2 Management
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonjabulo Ntombikhona Magwaza, et al.
(2024)
Open Access | Times Cited: 1

Nanomechanical footprint of SARS-CoV-2 variants in complex with a potent nanobody by molecular simulations
Luis Fernando Cofas‐Vargas, Gustavo E. Olivos-Ramírez, Mateusz Chwastyk, et al.
Nanoscale (2024)
Open Access | Times Cited: 1

Efficacy of convalescent plasma in hospitalized COVID-19 patients: findings from a controlled trial
Tânia Portella Costa, Mateus Nóbrega Aoki, Camilla Moreira Ribeiro, et al.
Brazilian Journal of Medical and Biological Research (2024) Vol. 57
Open Access | Times Cited: 1

Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumors
Karthikeyan Subbarayan, Ahmed Al‐Samadi, Helene Schäfer, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 1

Investigating the potential mechanism of quercetin against cervical cancer
Man Chu, Huihui Ji, Kehan Li, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4

A potent neutralizing nanobody targeting a unique epitope on the receptor-binding domain of SARS-CoV-2 spike protein
Yuting Zhang, Dan Wang, Qi Xiang, et al.
Virology (2023) Vol. 589, pp. 109925-109925
Closed Access | Times Cited: 3

Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumors
Karthikeyan Subbarayan, Ahmed Al‐Samadi, Helene Schäfer, et al.
Research Square (Research Square) (2024)
Closed Access

Exploring the treatment of SARS-CoV-2 with modified vesicular stomatitis virus
Nishnath Polavarapu, Madison Doty, Hana M. Dobrovolny
Journal of Theoretical Biology (2024), pp. 111959-111959
Closed Access

Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5
Inna V. Dolzhikova, А. И. Тухватулин, Daria M. Grousova, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1152-1152
Open Access

Mechanistic Insights into the Mutational Landscape of the Main Protease/3CLPro and Its Impact on Long-Term COVID-19/SARS-CoV-2 Management
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonjabulo Ntombikhona Magwaza, et al.
Future Pharmacology (2024) Vol. 4, Iss. 4, pp. 825-852
Open Access

Interferon therapy in alpha and Delta variants of SARS-CoV-2: The dichotomy between laboratory success and clinical realities
Atefe Alirezaee, Milad Mirmoghtadaei, Hanieh Heydarlou, et al.
Cytokine (2024) Vol. 186, pp. 156829-156829
Closed Access

A Bayesian walker coupled with a computational workflow that generates the micro-evolution of SARS-CoV-2 and makes predictions of new mutations that can emerge
Ben Geoffrey A S, Judith Gracia
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 21, pp. 11603-11611
Closed Access | Times Cited: 1

Page 1

Scroll to top